axillary osmidrosis
Conditions
Interventions
Experimental group:Single-incision surgery with CareSYS I for axillary osmidrosis
control group:Single-incision surgery with scissor for axillary osmidrosis
Sponsors
The First Affiliated Hospital of Army Medical University, PLA
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Age greater than or equal to 18 years old, and not more than 65 years old; 2) BMI>=18.5kg/m2 and <30kg/m2 3) Subjective and objective underarm odor; 4) Be able to understand the content of the research and voluntarily agree to conduct the research; 5) The investigator determined that either of the two treatment modalities was suitable
Exclusion criteria
Exclusion criteria: 1) There are local scars, ulcers, inflammatory skin diseases in the armpits, and obvious hypertrophic scars or keloids; 2) Those who have undergone axillary odor surgery in the past, and those who have undergone botulinum toxin type A injection, laser or radiofrequency treatment for axillary odor within the previous 6 months; 3) pregnant and lactating women; 4) Those who need to receive systemic immunosuppressant therapy (including glucocorticoids), cytotoxic drugs, and anticoagulant drugs in the past 30 days or during the expected research process; 5) Patients with hematopoietic dysfunction and coagulation dysfunction (such as hemophilia); 6) Accompanied by diabetes, hypertension, coronary heart disease, vascular diseases (including peripheral vascular diseases without reconstruction, vasculitis, etc.), pyoderma or lymphedema; 7) Patients with poor systemic nutritional status, immunodeficiency or hypocompromise, including: autoimmune diseases, malignant tumors, tuberculosis and other serious underlying diseases, patients with acquired immunodeficiency syndrome (AIDS) or patients infected with human immunodeficiency virus (HIV); 8) Those who have acute or chronic bacterial, viral or fungal skin diseases that may interfere with wound healing; 9) Those with mental illness or psychological disorders; 10) Other conditions judged by the investigator to be unsuitable for enrollment, such as: inability to tolerate surgery, poor compliance, difficulty in follow-up, etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comprehensive satisfaction scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Therapeutic effect;Duration of surgery;VSS (Vancouver Scar Scale) Score;OSAS (Observer Scar Score) ;PSAS (Patient Scar Assessment Score);Complication rate;Reduction of axillary hair;Reduction of axillary sweating;DLQI Score; | — |
Countries
China
Contacts
Public ContactZhang Jiaping
The First Affiliated Hospital of Army Medical University, PLA
Outcome results
None listed